113 related articles for article (PubMed ID: 16816571)
1. HIV therapy, hepatitis C virus infection, antibiotics and obesity, a mitochondria killer mix?
Côté HC; Brumme ZL; Chan JW; Guillemi S; Montaner JS; Harrigan PR
AIDS; 2006 Jun; 20(9):1343-5. PubMed ID: 16816571
[No Abstract] [Full Text] [Related]
2. Hepatic steatosis and ddI, d4T use.
Bernard EJ
IAPAC Mon; 2006 Jul; 12(7):240-1. PubMed ID: 17096496
[No Abstract] [Full Text] [Related]
3. Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus.
Lai AR; Tashima KT; Taylor LE
AIDS Patient Care STDS; 2006 Oct; 20(10):678-92. PubMed ID: 17052138
[TBL] [Abstract][Full Text] [Related]
4. Dideoxynucleoside analogues should be used cautiously in patients with hepatic steatosis.
Zeremski M; Talal AH
Clin Infect Dis; 2006 Aug; 43(3):373-6. PubMed ID: 16804854
[No Abstract] [Full Text] [Related]
5. Human immunodeficiency virus and hepatitis C virus co-infection.
Vlahakis SR
J Med Liban; 2006; 54(2):106-10. PubMed ID: 17087002
[TBL] [Abstract][Full Text] [Related]
6. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
7. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
Vispo E; Maida I; Barreiro P; Moreno V; Soriano V
HIV Clin Trials; 2008; 9(6):440-4. PubMed ID: 19203910
[TBL] [Abstract][Full Text] [Related]
8. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
9. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
Remtulla RA; Decker CF
Clin Infect Dis; 2008 Nov; 47(9):1233-4; author reply 1234. PubMed ID: 18831698
[No Abstract] [Full Text] [Related]
11. Nevirapine levels may predict toxicity.
TreatmentUpdate; 2002 Feb; 14(2):6-7. PubMed ID: 12691043
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus and metabolic disturbances.
Nuñez M
IAPAC Mon; 2005 Jul; 11(7):216-7. PubMed ID: 16676426
[No Abstract] [Full Text] [Related]
13. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
[TBL] [Abstract][Full Text] [Related]
14. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
Cooper CL; Mills E
Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
[TBL] [Abstract][Full Text] [Related]
15. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
[TBL] [Abstract][Full Text] [Related]
16. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
Ingiliz P; Benhamou Y
J HIV Ther; 2009 Mar; 14(1):3-7. PubMed ID: 19731558
[No Abstract] [Full Text] [Related]
17. Clinicopathological conference: hepatitis C in a patient with human immunodeficiency virus infection.
Dove LM; Alonzo J; Wright TL
Hepatology; 2000 Jul; 32(1):147-52. PubMed ID: 10869303
[No Abstract] [Full Text] [Related]
18. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
19. Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient.
Piroth L; Grappin M; Sgro C; Buisson M; Duong M; Chavanet P
Ann Pharmacother; 2000 Apr; 34(4):534-5. PubMed ID: 10772444
[No Abstract] [Full Text] [Related]
20. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
Valle Tovo C; Alves de Mattos A; Ribeiro de Souza A; Ferrari de Oliveira Rigo J; Lerias de Almeida PR; Galperim B; Riegel Santos B
Liver Int; 2007 Feb; 27(1):40-6. PubMed ID: 17241379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
